
Noventure signs exclusive license agreement for innovative food supplement EPA3G
Barcelona, Spain, February 17, 2021 – Noventure announces today that it has signed an exclusivity agreement for the licensing of…
Barcelona, Spain, February 17, 2021 – Noventure announces today that it has signed an exclusivity agreement for the licensing of…
Paris, France and Cambridge, MA, USA, February 16, 2021 – Biomunex Pharmaceuticals, a biopharmaceutical company that develops cutting-edge immunotherapy through…
Barcelona, Spain, February 10, 2021 – Accure Therapeutics, a private translational R&D engine at clinical stage in the Central Nervous System…
Écouen, France, February 3, 2021 — Vygon, a specialist single-use medical devices group, is taking part in World Cancer Day…
Louvain-la-Neuve, Belgium, February 3, 2021 – The Minafin Group, a leading developer and manufacturer of fine chemicals for the life…
Lyon, France, February 1, 2021 – Tollys, a biopharmaceutical company developing TL-532, the first synthetic specific agonist of Toll-like receptor…